gip/glp-1; tirzepatide; obesity; weight loss

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011940/?fbclid=IwAR2tVliRNZld3ui2Kp70UeUrWFWsRaG5vphx8EF13fdB4aUn-vBc0v1aEKY_aem_AbqXSwyVpOvYCcYGlesCJW4UniV_Gzu02SPO3aX-qfs_8EF0ogIva-jCpe-_fAOuAmA#:~:text=In%20conclusion%2C%2024%2Dweek%20treatment,induced%20improvement%20of%20glycemic%20control

In this video, Mark Scholz and Mark Moyad discuss the pros and cons of weight loss drugs, particularly those that have shown significant weight loss results in patients. They emphasize that these drugs are not for cosmetic purposes, but for individuals with severe weight-related health issues...

https://www.hcplive.com/view/tirzepatide-bests-semaglutide-for-a1c-weight-loss-in-indirect-comparison-of-clinical-trial-data A network meta-analysis suggests tirzepatide may be more effective than semaglutide in reducing HbA1c and body weight in type 2 diabetes but may increase gastrointestinal...

The type 2 diabetes drug tirzepatide has been reported to induce weight loss in patients with diabetes. A new randomized trial reports weight loss with tirzepatide in patients without diabetes. These findings are summarized in a short video.

Tirzepatide Once Weekly for the Treatment of Obesity (2022) Ania M. Jastreboff, M.D., Ph.D., Louis J. Aronne, M.D., Nadia N. Ahmad, M.D., M.P.H., Sean Wharton, M.D., Pharm.D., Lisa Connery, M.D., Breno Alves, M.D., Arihiro Kiyosue, M.D., Ph.D., Shuyu Zhang, M.S., Bing Liu, Ph.D., Mathijs C...